About Aqualor
Aqualor is a Healthcare company based in Russia founded in 2007, and was acquired by Stada in October 2013. Manufacturer of nasal drugs. Its chief executive, as recorded, is Peter Goldschmidt. Its website aqualor.ru draws about 119 thousand monthly visits. Its focus areas include Traditional Pharmaceuticals.
Company details
Aqualor, established in 2007 and currently in Acquired stage, focuses on providing healthcare solutions, and traditional pharmaceuticals. Manufacturer of nasal drugs. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Russia
- Stage Acquired
- SectorsHealthcare
- Website category Health · Pharmacy
- Email••••••••
- Phone•••• ••••
- Website aqualor.ru
- Acquired by Stada (Oct 2013)
Investors in Aqualor
Aqualor has secured backing from 1 investor. Prominent investors backing the company include Stada.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of generics and biosimilars | 1895 | stada.com | Bad Vilbel, Germany |
Investor details for Aqualor
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Aqualor
1 people are tracked at Aqualor (1 in leadership).
| Name | Role | Group |
|---|---|---|
Peter Goldschmidt | CEO | Leadership |
Complete people profiles for Aqualor
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Aqualor
2 dated milestones of Aqualor across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Aqualor is founded.
- Exit Acquired by Stada.
Web traffic of Aqualor
The website of Aqualor (aqualor.ru) receives about 119K visits a month and ranks #388,367 among all websites worldwide, #719 in Pharmacy.
- Monthly visits119K
▲ 0.7% vs previous month
- Unique visitors71.7K
per month
- Global rank#388,367
among all websites
- Category rank#719
Health · Pharmacy
- Bounce rate66%
- Pages per visit1.5
- Average visit1 min 03 sec
- DevicesDesktop 13% · Mobile 87%
Websites whose visitors overlap most with Aqualor. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| dolphin.ru | 100% | 15K | #1,579,133 | View details | |
sialor.ru | sialor.ru | 94% | #990,696 | – | |
evamenol.ru | evamenol.ru | 93% | #615,175 | – | |
piluli.ru | piluli.ru | 85% | – | ||
cytovir.ru | cytovir.ru | 84% | #355,596 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Aqualor
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Aqualor
Aqualor was founded in 2007.
Aqualor is headquartered in Russia.
Peter Goldschmidt is the CEO of Aqualor, as recorded in our data.
Aqualor, established in 2007 and currently in Acquired stage, focuses on providing healthcare solutions, and traditional pharmaceuticals. Manufacturer of nasal drugs. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.
Aqualor has 1 investor. Key investors include Stada.
Yes. Aqualor was acquired by Stada in October 2013.
The website of Aqualor receives about 119 thousand visits a month and ranks #388,367 among all websites worldwide.